Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02179450
Other study ID # Cognition_Facial palsy
Secondary ID
Status Completed
Phase N/A
First received December 31, 2012
Last updated June 30, 2014
Start date August 2012
Est. completion date December 2013

Study information

Verified date June 2014
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority Austria: Ethikkommission
Study type Observational

Clinical Trial Summary

Based on recent findings that botulinum toxin injections in the cranial muscles might reduce emotional processing (Havas 2011), an increasing number of popular newspaper tabloids are suggesting a negative effect on cognition. The underlying research articles address the "facial feedback hypothesis". The hypothesis indicates that expressive behaviour, including facial mimic expressions influences the subject's brain via feedback. (Alam 2008) Other systemic neurological diseases, e.g of inflammatory origin, may lead to temporary bilateral facial nerve palsy (BF). During recovery process, the palsy usually remits completely.

The effect of bilateral facial muscle palsy on cognition and emotional possessing has never been evaluated.

The results of this pilot study might provide new information about the effect bilateral facial palsy on emotional processing and cognition and the facial feedback hypothesis.

The aim of this controlled pilot study is to assess cognitive function and emotional processing in patients with bilateral facial palsy. In addition, differences in cognitive function and emotional processing in patients with different manifestations of dystonia should be evaluated.

According to the facial feedback theory, paralysed mimic muscles might alter emotional processing. Therefore, investigators compare patients with bilateral facial muscle palsy and healthy controls. Investigators expect no influence of facial muscle palsy on cognitive functions in any of the tested groups; the investigators expect a mild impairment of emotional processing only in the patients group with bilateral facial muscle palsy (BEB and BF). In addition, the investigators expect no difference in emotional processing in patients with different manifestations of dystonia (BEB and CD) at remission. There might be a slight difference of emotional processing in patients with different manifestations of dystonia (BEB and CD) at time of prominent facial palsy.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date December 2013
Est. primary completion date May 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

Patients:

- willing to participate in this pilot trial

- bilateral facial palsy

- age 18-80 years

Control:

- willing to participate in this pilot trial

- age,

- gender and

- education (duration of school attendance) matched

- and/or cervical dystonia

Exclusion Criteria:

- neurological or psychiatric comorbidity

- psychotropic drugs

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Austria Department of Neurology, Medical University of Vienna Vienna

Sponsors (1)

Lead Sponsor Collaborator
Kirsten Elwischger, MD

Country where clinical trial is conducted

Austria, 

References & Publications (3)

Alam M, Barrett KC, Hodapp RM, Arndt KA. Botulinum toxin and the facial feedback hypothesis: can looking better make you feel happier? J Am Acad Dermatol. 2008 Jun;58(6):1061-72. doi: 10.1016/j.jaad.2007.10.649. Review. — View Citation

Havas DA, Glenberg AM, Gutowski KA, Lucarelli MJ, Davidson RJ. Cosmetic use of botulinum toxin-a affects processing of emotional language. Psychol Sci. 2010 Jul;21(7):895-900. doi: 10.1177/0956797610374742. Epub 2010 Jun 14. — View Citation

Hennenlotter A, Dresel C, Castrop F, Ceballos-Baumann AO, Wohlschläger AM, Haslinger B. The link between facial feedback and neural activity within central circuitries of emotion--new insights from botulinum toxin-induced denervation of frown muscles. Cereb Cortex. 2009 Mar;19(3):537-42. doi: 10.1093/cercor/bhn104. Epub 2008 Jun 17. Erratum in: Cereb Cortex. 2010 Jan;20(1):253. Baumann, Andres O Ceballos [corrected to Ceballos-Baumann, Andres O]. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary I-S-T-2000R- (intelligence-structure-test 2000R) Test to evaluate Intelligence
Subtest "Matrixes"
Subtest "Analogies"
up to four weeks No
Secondary Beck's depression-inventory-II Evaluation of depression (BDI-II; Hautzinger et al., 2009) up to four weeks No
Secondary Apathy Evaluation Scale Evaluation of apathy (AES; Luecken et al., 2006) up to four weeks No
See also
  Status Clinical Trial Phase
Completed NCT02194907 - Emotion Study -- A Neurofeedback Approach N/A
Recruiting NCT03554694 - Gut-brain Axis, Brain Function, and Behaviour. N/A
Recruiting NCT03085628 - Sex- and Context-dependent Effects of Oxytocin on Social Reward Processing N/A
Completed NCT03688048 - Effects of a Single Dose of Bright Light Treatment on Measures of Affective Information Processing N/A
Completed NCT02839395 - The Effects of Acute vs. Chronic of Screen Illumination on: Sleep Efficacy and Architecture, Physiology, Emotion and Behavior: Possible Effect on Human Health N/A
Completed NCT02219620 - Examining the Effects of (MiM) Treatment on Emotional and Cognitive Functioning of Residents in Long-term Care N/A
Completed NCT03623477 - Can Cognitive Training Decrease Reactive Aggression? N/A
Completed NCT02301715 - Effects of Intranasal Oxytocin on Emotion Regulation in Adolescents Phase 1